Type: device
Status: Investigational
Developer: Trinity Biotech
15-day multi-sensor CGM with built-in AI analytics. Tracks glucose plus additional biomarkers. Represents the shift toward AI-native CGM systems that provide actionable insights.
15-day multi-sensor CGM with built-in AI analytics tracking glucose plus additional biomarkers
Year: 2026